Related Experiment Video
Updated: Jul 15, 2025

Measuring Local Anaphylaxis in Mice
Published on: October 14, 2014
Fatal ampicillin-sulbactam anaphylaxis in a 34-year-old male
Marielle C Young1, Chantal Lemoine1, John J O Accarino1
1Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass.
Abstract:
A 34-year-old man receiving his first dose of ampicillin-sulbactam for osteomyelitis in a hospital setting experienced fatal drug-induced anaphylaxis.
Insights
A patient died from a severe allergic reaction to ampicillin-sulbactam, a common antibiotic used to treat bone infections. This case highlights the critical risk of drug-induced anaphylaxis, even with initial antibiotic doses.
Area of Science:
- Pharmacology
- Clinical Medicine
- Immunology
Background:
- Osteomyelitis is a serious bone infection often requiring antibiotic treatment.
- Ampicillin-sulbactam is a commonly prescribed antibiotic combination for bacterial infections.
- Drug-induced anaphylaxis is a rare but life-threatening allergic reaction.
Observation:
- A 34-year-old male patient was admitted for treatment of osteomyelitis.
- The patient received his first dose of intravenous ampicillin-sulbactam.
- The patient rapidly developed symptoms consistent with anaphylaxis.
Findings:
- The patient experienced fatal drug-induced anaphylaxis following the initial administration of ampicillin-sulbactam.
- The event underscores the potential for severe allergic reactions to antibiotics, irrespective of prior exposure.
Implications:
- Healthcare providers must remain vigilant for anaphylaxis, even with first-time antibiotic use.
- Prompt recognition and management of anaphylaxis are crucial for patient survival.
- This case emphasizes the importance of antibiotic stewardship and allergy screening.
More Related Videos
12:18Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Allergic Reactions
Acute Pyelonephritis II: Diagnostic Studies and Management
Depolarizing Blockers: Pharmocokinetics
Desensitization and Tachyphylaxis
Allergic Drug Reactions